‘Kinder’ treatment for childhood brain cancer to be offered by NHS in England
by The Guardian
The Guardian— Dabrafenib with trametinib can halt growth of some tumours for more than three times as long as standard chemotherapy, study showsThe NHS is to offer children with brain tumours in England a groundbreaking new targeted drug therapy to tackle the disease – a development charities are hailing as the biggest breakthrough in decades.Gliomas are the most common type of brain cancer in children but experts say the standard treatment of chemotherapy can be brutal and gruelling, and also carries the...
The Independent—New targeted treatment approved for children with brain cancer. The drugs improve children’s response rate to treatment and survival time without the disease getting worse.
The Guardian—‘Life-changing’ drug for sickle cell disease to be offered by NHS in England. Voxelotor, which can help reduce need for blood transfusions, is administered as a daily tabletA new treatment for sickle cell disease has been recommended by the health watchdog in a move described as life-changing for people living with the condition in England.The drug, Voxelotor, has been recommended for use on the NHS in England by the National Institute for Health and Care Excellence (Nice) in people with the disease who are aged 12 and over. Continue reading
The Independent—New NHS treatment could transform lives of thousands of children with brain tumours. Combination of dabrafenib and trametinib can now be used for patients aged one and over